🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A great study answers a clinical question And this is a great study Does one kind of steroid help patients with alcohol-associated hepatitis more than the other? No journals.lww.com/hepcomm/fullte… Hepatology Communications Juan Pablo (JP) Arab, MD 

1/17 people with a rare disease 🔎 Many wait years for a diagnosis 💊 Only 5% have a treatment 👫🏻 Too many families w/o support Need to fix this! Come and visit #RAREfest24 Today 10-16:30, Cambridge Guildhall Program 👉🏼 heyzine.com/flip-book/2de0… Cambridge Rare Disease Network (CamRARE) Cambridge Stem Cell Institute

We put some provocative statements herein, hope to see a good discussion: journals.lww.com/hep/abstract/9…

Evolution of morphological changes in donor livers undergoing normothermic machine perfusion - Paterson - Histopathology - Wiley Online Library #liverpath onlinelibrary.wiley.com/doi/full/10.11…

Pliant Therapeutics presented new data on their bexotegrast program at The Liver Meeting® earlier this month. Findings highlighted its potential to reduce fibrosis and inflammation in liver diseases, including PSC. Learn more: buff.ly/4120OdY #LetsBeatPSC

YES-NO flowchart for early career fellows Key readouts: 🏠 Establish a well-defined niche ✨ Know your limits and effectiveness 🕒 3S time management: Substitution-Segmentation-Scheduling 👨‍👩‍👧 Build a mentorship team My own: 👠 Keep trying. Stop whining

All the info about upcoming Cambridge Hepatology Research Seminars (organised by @Matt_Hoare20) are available here sites.google.com/cam.ac.uk/eci-… Next one is TUES 10th Dec Sofia Ferreira from The University of Edinburgh Primary cilia dynamics in liver senescence and regeneration

🟪NEW Article in press❕ Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Epidemiology, Mortality, and Impact of Diagnostic Sequence 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter #PrimarySclerosingCholangitis

This large study has a positive result that needs to be highlighted: CONSULTING AN ADDICTION SPECIALIST DECREASES MORTALITY IN ALCOHOL-ASSOCIATED HEPATITIS. We must do it. t.ly/yugVi

Fibrates and other PPAR agonists are so hot right now 🔥🔥🔥 Here is a review of how they work, the evidence of benefit, and the bright future of this pathway in improving liver health journals.lww.com/hepcomm/fullte…

We're closing out the year with our annual editors' selection of highlights from The Lancet Gastroenterology & Hepatology... Follow the🧵below! #GITwitter #LiverTwitter #MedTwitter

📝 Hot off the press! Leveraging AI to improve diagnostic accuracy in #AIH. A huge leap in reducing diagnostic error & improving patient care #compath Collaborative work with Jakob Nikolas Kather, led by Alessio Gerussi Università degli Studi di Milano-Bicocca EASL Education ESOTtransplant jhep-reports.eu/article/S2589-…

‼️📣 Calling ALL GI doctors (including those currently in training) 📣‼️ Me and Tamara Milovanovic need your answers about the knowlege regarding harmful effects of alcohol among GI doctors. (De-identified) SURVEY LINK and PREAMBLE below: docs.google.com/forms/d/e/1FAI…

#Liver disease is now the 2nd commonest cause of preventable death in the UK. Please vote to increase awareness of #clinicaltrials for new treatments! BASL education feed British Liver Trust Royal Free London #livertwitter

In press on CGH our multicenter study 🇮🇹 🇬🇧 on 293 pts with PBC 🔥 Non-invasive tests for portal hypertension perform poorly when cholestasis is severe. 👊RESIST criteria (PLT+albumin) outperform stiffness-based criteria Vincenza Calvaruso Marco Carbone cghjournal.org/article/S1542-…

Everything you needed to know about diagnosis of Wilson’s disease in one short video! Please share and RT. British Liver Trust BASL education feed BASL

Here are some good reasons for scientists to join #Bluesky for a safer place to learn

I’m an #NIH-funded researcher, drowning in uncertainty “I’ll keep doing what I can to move my research forward. But I, and so many others, can’t do this indefinitely,” this assistant professor (@vjrphd) writes. bit.ly/41pm0KI

I have continued to post here I will be deleting the app for a while and focus on bluer skies Let’s see if we can migrate together